Cited by 583Alzheimer's disease research and treatmentsNeurological Disease Mechanisms and TreatmentsAmyotrophic Lateral Sclerosis Research

The DOI matches its Crossref record; 151 of the 151 references it cites were found in a registry or an index.

Animal models of neurodegenerative diseases

Open access

Dawson, Ted M., Golde, Todd E., Lagier-Tourenne, Clotilde·2018·Nature Neuroscience

DOI 10.1038/s41593-018-0236-8PMC PMC6615039

Open this paper in CoChat — free account

Abstract

Animal models of adult-onset neurodegenerative diseases have enhanced the understanding of the molecular pathogenesis of Alzheimer's disease, Parkinson's disease, frontotemporal dementia, and amyotrophic lateral sclerosis. Nevertheless, our understanding of these disorders and the development of mechanistically designed therapeutics can still benefit from more rigorous use of the models and from generation of animals that more faithfully recapitulate human disease. Here we review the current state of rodent models for Alzheimer's disease, Parkinson's disease, frontotemporal dementia, and amyotrophic lateral sclerosis. We discuss the limitations and utility of current models, issues regarding translatability, and future directions for developing animal models of these human disorders.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/s41593-018-0236-8

Cites

151 of 151 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

1 retracted

Intraneuronal APP, Not Free Aβ Peptides In 3xTg-AD Mice: Implications For Tau Versus Aβ Mediated Alzheimer Neurodegeneration
Winton, M. J., Lee, E. B., Sun, E., Wong, M. M., Leight, S., Zhang, B., Trojanowski, J., & Lee, V. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.6637-10.2011 · Cited by 110
Retracted
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
α-Synuclein in Lewy bodies
Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382
Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis
Neumann, M., Sampathu, D. M., Kwong, L. K., Truax, A. C., Micsenyi, M. C., Chou, T. T., Bruce, J., Schuck, T., Grossman, M., Clark, C. M., et al. (2006) · Science · doi:10.1126/science.1134108 · Cited by 6,576
Prions
Prusiner, S. B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13363 · Cited by 5,373
Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS
DeJesus-Hernandez, M., Mackenzie, I. R., Boeve, B. F., Boxer, A. L., Baker, M., Rutherford, N. J., Nicholson, A. M., Finch, N. A., Flynn, H., Adamson, J., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.011 · Cited by 4,936 · cited 1×
“Pathological changes in dopaminergic nerve cells of the substantia nigra and olfactory bulb in mice transgenic for truncated human alpha-synuclein(1-120): implications for Lewy body disorders.”
A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD
Renton, A. E., Majounie, E., Waite, A., Simón-Sánchez, J., Rollinson, S., Gibbs, J. R., Schymick, J. C., Laaksovirta, H., van Swieten, J. C., Myllykangas, L., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.010 · Cited by 4,409
Meta-Analysis of 74,046 Individuals Identifies 11 New Susceptibility Loci for Alzheimer’s Disease
(EADI), E. A. D. I., Lambert, J.-C., (GERAD), G. A. E. R. I. A. D., Alzheimer's Disease Genetic Consortium (ADGC), (CHARGE), C. F. H. A. A. R. I. G. E., Ibrahim-Verbaas, C. A., Harold, D., Naj, A. C., Sims, R., Bellenguez, C., et al. (2013) · Nature Genetics · doi:10.1038/ng.2802 · Cited by 4,336
Motor Neuron Degeneration in Mice that Express a Human Cu,Zn Superoxide Dismutase Mutation
Gurney, M. E., Pu, H., Chiu, A. Y., Dal Canto, M. C., Polchow, C. Y., Alexander, D. D., Caliendo, J., Hentati, A., Kwon, Y. W., Deng, H.-X., et al. (1994) · Science · doi:10.1126/science.8209258 · Cited by 4,143
Triple-Transgenic Model of Alzheimer’s Disease with Plaques and Tangles
Oddo, S., Caccamo, A., Shepherd, J. D., Murphy, M. P., Golde, T. E., Kayed, R., Metherate, R., Mattson, M. P., Akbari, Y., & LaFerla, F. M. (2003) · Neuron · doi:10.1016/s0896-6273(03)00434-3 · Cited by 4,126
Self-citation

Show all 151 references

Sorted by citations

Alzheimer disease
Knopman, D. S., Amieva, H., Petersen, R. C., Chételat, G., Holtzman, D. M., Hyman, B. T., Nixon, R. A., & Jones, D. T. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00269-y · Cited by 2,606
The gut microbiota–brain axis in behaviour and brain disorders
Morais, L. H., Schreiber, H. L., & Mazmanian, S. K. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-020-00460-0 · Cited by 2,149
Development of a Chimeric Model to Study and Manipulate Human Microglia In Vivo
Hasselmann, J., Coburn, M. A., England, W., Figueroa Velez, D. X., Kiani Shabestari, S., Tu, C. H., McQuade, A., Kolahdouzan, M., Echeverria, K., Claes, C., et al. (2019) · Neuron · doi:10.1016/j.neuron.2019.07.002 · Cited by 380
Microglia: Agents of the CNS Pro-Inflammatory Response
Rodríguez-Gómez, J. A., Kavanagh, E., Engskog-Vlachos, P., Engskog, M. K. R., Herrera, A. J., Espinosa-Oliva, A. M., Joseph, B., Hajji, N., Venero, J. L., & Burguillos, M. A. (2020) · Cells · doi:10.3390/cells9071717 · Cited by 365
Immune Signaling in Neurodegeneration
Hammond, T. R., Marsh, S. E., & Stevens, B. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.016 · Cited by 336
The Impact of Systemic Inflammation on Alzheimer’s Disease Pathology
Xie, J., Van Hoecke, L., & Vandenbroucke, R. E. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.796867 · Cited by 324
Enhancing glycolysis attenuates Parkinson’s disease progression in models and clinical databases
Cai, R., Zhang, Y., Simmering, J. E., Schultz, J. L., Li, Y., Fernandez-Carasa, I., Consiglio, A., Raya, A., Polgreen, P. M., Narayanan, N. S., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci129987 · Cited by 286
The Potential Use of Plant Natural Products and Plant Extracts with Antioxidant Properties for the Prevention/Treatment of Neurodegenerative Diseases: In Vitro, In Vivo and Clinical Trials
Pohl, F., & Lin, P. K. T. (2018) · Molecules · doi:10.3390/molecules23123283 · Cited by 284
Neuroinflammation in frontotemporal dementia
Bright, F., Werry, E. L., Dobson-Stone, C., Piguet, O., Ittner, L. M., Halliday, G. M., Hodges, J. R., Kiernan, M. C., Loy, C. T., Kassiou, M., et al. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0231-z · Cited by 280
Identification of neural oscillations and epileptiform changes in human brain organoids
Samarasinghe, R. A., Miranda, O. A., Buth, J. E., Mitchell, S. A., Ferando, I., Watanabe, M., Allison, T. F., Kurdian, A., Fotion, N. N., Gandal, M. J., et al. (2021) · Nature Neuroscience · doi:10.1038/s41593-021-00906-5 · Cited by 288
Lysosomal dysfunction in neurodegeneration: emerging concepts and methods
Udayar, V., Chen, Y., Sidransky, E., & Jagasia, R. (2022) · Trends in Neurosciences · doi:10.1016/j.tins.2021.12.004 · Cited by 255
Protein neddylation and its role in health and diseases
Zhang, S., Yu, Q., Li, Z., Zhao, Y., & Sun, Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01800-9 · Cited by 171
Precision drug delivery to the central nervous system using engineered nanoparticles
Gao, J., Xia, Z. J., Gunasekar, S., Jiang, C., Karp, J. M., & Joshi, N. (2024) · Nature Reviews Materials · doi:10.1038/s41578-024-00695-w · Cited by 163
Implications of Gut Microbiota in Neurodegenerative Diseases
Zhang, H., Chen, Y., Wang, Z., Xie, G., Liu, M., Yuan, B., Chai, H., Wang, W., & Cheng, P. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.785644 · Cited by 161
Recent Advancements of Nanomedicine in Neurodegenerative Disorders Theranostics
Mukherjee, S., Madamsetty, V. S., Bhattacharya, D., Roy Chowdhury, S., Paul, M. K., & Mukherjee, A. (2020) · Advanced Functional Materials · doi:10.1002/adfm.202003054 · Cited by 152
Human iPSC‐derived microglia: A growing toolset to study the brain's innate immune cells
Hasselmann, J., & Blurton‐Jones, M. (2020) · Glia · doi:10.1002/glia.23781 · Cited by 145
Stem Cells, Genome Editing, and the Path to Translational Medicine
Soldner, F., & Jaenisch, R. (2018) · Cell · doi:10.1016/j.cell.2018.09.010 · Cited by 144
Mechanobiology of the brain in ageing and Alzheimer's disease
Hall, C. M., Moeendarbary, E., & Sheridan, G. K. (2020) · European Journal of Neuroscience · doi:10.1111/ejn.14766 · Cited by 140
QUINT: Workflow for Quantification and Spatial Analysis of Features in Histological Images From Rodent Brain
Yates, S. C., Groeneboom, N. E., Coello, C. S., Lichtenthaler, S. F., Kuhn, P., Demuth, H.-U., Hartlage‐Rübsamen, M., Roßner, S., Leergaard, T. B., Kreshuk, A., et al. (2019) · Frontiers in Neuroinformatics · doi:10.3389/fninf.2019.00075 · Cited by 136
Transgenic Mouse Models of Alzheimer’s Disease: An Integrative Analysis
Sanchez-Varo, R. M., Mejias‐Ortega, M., Fernandez-Valenzuela, J. J., Nuñez‐Diaz, C., Cáceres-Palomo, L., Vegas‐Gomez, L., Sánchez‐Mejías, E., Trujillo‐Estrada, L., García‐León, J. A., Moreno‐González, I., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105404 · Cited by 136
Neuroinflammation in Neurodegenerative Disorders: Current Knowledge and Therapeutic Implications
Giri, P. M., Banerjee, A., Ghosal, A., & Layek, B. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25073995 · Cited by 129
Map kinase signaling as therapeutic target for neurodegeneration
Ahmed, T., Zulfiqar, A., Argüelles, S., Rasekhian, M., Nabavi, S. F., Sanches-Silva, A. T., & Nabavi, S. M. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105090 · Cited by 123
Disease-Modifying Therapies for Alzheimer’s Disease: More Questions than Answers
Golde, T. E. (2022) · Neurotherapeutics · doi:10.1007/s13311-022-01201-2 · Cited by 119
Self-citation
Behavioral Tests in Neurotoxin-Induced Animal Models of Parkinson’s Disease
Prasad, E. M., & Hung, S. (2020) · Antioxidants · doi:10.3390/antiox9101007 · Cited by 125
Contribution of astrocytes to neuropathology of neurodegenerative diseases
Acıoğlu, Ç., Li, L., & Elkabes, S. (2021) · Brain Research · doi:10.1016/j.brainres.2021.147291 · Cited by 119
Genome-scale metabolic network reconstruction of model animals as a platform for translational research
Wang, H., Robinson, J. L., Kocabaş, P., Gustafsson, J., Anton, M., Cholley, P., Huang, S., Gobom, J., Svensson, T., Uhlén, M., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2102344118 · Cited by 126
Generation of a humanized Aβ expressing mouse demonstrating aspects of Alzheimer’s disease-like pathology
Baglietto‐Vargas, D., Forner, S., Cai, L., Martini, A. C., Trujillo‐Estrada, L., Swarup, V., Nguyen, M. M. T., Huynh, K. D., Javonillo, D. I., Tran, K. M., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22624-z · Cited by 120
Organotypic brain slice cultures to model neurodegenerative proteinopathies
Croft, C. L., Futch, H. S., Moore, B. D., & Golde, T. E. (2019) · Molecular Neurodegeneration · doi:10.1186/s13024-019-0346-0 · Cited by 123
Self-citation
Improved modeling of human AD with an automated culturing platform for iPSC neurons, astrocytes and microglia
Bassil, R., Shields, K., Granger, K., Zein, I., Ng, S., & Chih, B. (2021) · Nature Communications · doi:10.1038/s41467-021-25344-6 · Cited by 106
Miniaturized head-mounted microscope for whole-cortex mesoscale imaging in freely behaving mice
Rynes, M. L., Surinach, D. A., Linn, S., LaRoque, M. C., Rajendran, V., Dominguez, J., Hadjistamoulou, O., Navabi, Z. S., Ghanbari, L., Johnson, G. W., et al. (2021) · Nature Methods · doi:10.1038/s41592-021-01104-8 · Cited by 108
Antisense Oligonucleotides for the Study and Treatment of ALS
Boros, B. D., Schoch, K. M., Kreple, C. J., & Miller, T. M. (2022) · Neurotherapeutics · doi:10.1007/s13311-022-01247-2 · Cited by 114
The A1 astrocyte paradigm: New avenues for pharmacological intervention in neurodegeneration
Hinkle, J. T., Dawson, V. L., & Dawson, T. M. (2019) · Movement Disorders · doi:10.1002/mds.27718 · Cited by 100
Self-citation
Group B Streptococcal Neonatal Meningitis
Tavares, T., Pinho, L., & Andrade, E. B. (2022) · Clinical Microbiology Reviews · doi:10.1128/cmr.00079-21 · Cited by 102
Gene therapy for CNS disorders: modalities, delivery and translational challenges
Gao, J., Gunasekar, S., Xia, Z. J., Shalin, K., Jiang, C., Chen, H., Lee, D., Lee, S., Pisal, N. D., Luo, J. N., et al. (2024) · Nature reviews. Neuroscience · doi:10.1038/s41583-024-00829-7 · Cited by 100
The Potential of Flavonoids and Flavonoid Metabolites in the Treatment of Neurodegenerative Pathology in Disorders of Cognitive Decline
Melrose, J. (2023) · Antioxidants · doi:10.3390/antiox12030663 · Cited by 97
Aβ plaques
Walker, L. C. (2020) · Free Neuropathology · doi:10.17879/freeneuropathology-2020-3025 · Cited by 113
Brain drug delivery and neurodegenerative diseases: Polymeric PLGA-based nanoparticles as a forefront platform
Pinto, M., Silva, V., Barreiro, S., Silva, R. V. D. S., Remião, F., Borges, F., & Fernandes, C. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101658 · Cited by 97
White matter microglia heterogeneity in the CNS
Amor, S., McNamara, N. B., Gerrits, E., Marzin, M. C., Kooistra, S. M., Miron, V. E., & Nutma, E. (2022) · Acta Neuropathologica · doi:10.1007/s00401-021-02389-x · Cited by 89
Multimodal mapping and analysis of the cyto- and receptorarchitecture of the human hippocampus
Palomero‐Gallagher, N., Kedo, O., Mohlberg, H., Zilles, K., & Amunts, K. (2020) · Brain Structure and Function · doi:10.1007/s00429-019-02022-4 · Cited by 90
Targeting Pathogenic Lafora Bodies in Lafora Disease Using an Antibody-Enzyme Fusion
Brewer, M. K., Uittenbogaard, A., Austin, G. L., Segvich, D. M., DePaoli-Roach, A. A., Roach, P. J., McCarthy, J. J., Simmons, Z. R., Brandon, J. A., Zhou, Z., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.07.002 · Cited by 89
Application of Human Brain Organoids—Opportunities and Challenges in Modeling Human Brain Development and Neurodevelopmental Diseases
Kim, S.-H., & Chang, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512528 · Cited by 96
Integrating deep learning and unbiased automated high-content screening to identify complex disease signatures in human fibroblasts
Schiff, L., Migliori, B., Chen, Y., Carter, D., Bonilla, C., Hall, J., Fan, M., Tam, E., Ahadi, S., Fischbacher, B., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28423-4 · Cited by 86
Hyperphosphorylated tau (p-tau) and drug discovery in the context of Alzheimer's disease and related tauopathies
Moore, K. B. E., Hung, T.-J., & Fortin, J. S. (2023) · Drug Discovery Today · doi:10.1016/j.drudis.2023.103487 · Cited by 93
Bifidobacterium breve HNXY26M4 Attenuates Cognitive Deficits and Neuroinflammation by Regulating the Gut–Brain Axis in APP/PS1 Mice
Zhu, G., Zhao, J., Wang, G., & Chen, W. (2023) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.3c00652 · Cited by 84
Neuroinflammation: Mechanisms, Dual Roles, and Therapeutic Strategies in Neurological Disorders
García‐Domínguez, M. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47060417 · Cited by 96
Biomarkers and therapeutic strategies targeting microglia in neurodegenerative diseases: current status and future directions
Noh, M., Kwon, H. S., Kwon, M., Nahm, M., Jin, H. K., Bae, J., & Kim, S. H. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00867-4 · Cited by 94
The Convergence of Alpha-Synuclein, Mitochondrial, and Lysosomal Pathways in Vulnerability of Midbrain Dopaminergic Neurons in Parkinson’s Disease
Minakaki, G., Krainc, D., & Burbulla, L. F. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.580634 · Cited by 87
Bioprinting Neural Systems to Model Central Nervous System Diseases
Qiu, B., Bessler, N., Figler, K. P., Buchholz, M., Rios, A. C., Malda, J., Levato, R., & Caiazzo, M. (2020) · Advanced Functional Materials · doi:10.1002/adfm.201910250 · Cited by 83
Re-thinking the Etiological Framework of Neurodegeneration
Castillo, X., Castro‐Obregón, S., Gutiérrez-Becker, B., Gutiérrez‐Ospina, G., Karalis, N., Khalil, A. A., López‐Noguerola, J. S., Rodríguez, L. L., Martínez‐Martínez, E., Perez‐Cruz, C., et al. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00728 · Cited by 80
Towards Visual Proteomics at High Resolution
Bäuerlein, F. J. B., & Baumeister, W. P. (2021) · Journal of Molecular Biology · doi:10.1016/j.jmb.2021.167187 · Cited by 79
New pathogenic insights from large animal models of neurodegenerative diseases
Yin, P., Li, S., Li, X., & Yang, W. (2022) · Protein & Cell · doi:10.1007/s13238-022-00912-8 · Cited by 79
Modeling late-onset Alzheimer’s disease neuropathology via direct neuronal reprogramming
Sun, Z., Kwon, J.-S., Ren, Y., Chen, S., Walker, C. K., Lu, X., Cates, K., Karahan, H., Sviben, S., Fitzpatrick, J. A. J., et al. (2024) · Science · doi:10.1126/science.adl2992 · Cited by 77
“It typically requires additional expression of human tau harboring mutations associated with primary tauopathy (94–96) or seeding mutant human APP knock-in mouse brain with human AD brain-derived tau (97) to develop the tau pathology.”
"Lipopolysaccharide-induced animal models for neuroinflammation – An overview."
Silva, A., Fiadeiro, M. B., Bernardino, L. I., Fonseca, C. P., Baltazar, G., & Cristóvão, A. C. (2023) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2023.578273 · Cited by 77
Animal Models for the Study of Human Disease
Morgan, S. J., Hutt, J. A., & Sura, R. (2023) · Springer eBooks · doi:10.1007/978-981-99-1284-1_15 · Cited by 74
Non-coding RNAs in Nervous System Development and Disease
Salvatori, B., Biscarini, S., & Morlando, M. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00273 · Cited by 74
Animal Models of Neurodegenerative Disease: Recent Advances in Fly Highlight Innovative Approaches to Drug Discovery
Tello, J. A., Williams, H., Eppler, R., Steinhilb, M. L., & Khanna, M. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.883358 · Cited by 77
The use of fibroblasts as a valuable strategy for studying mitochondrial impairment in neurological disorders
Olesen, M. A., Villavicencio-Tejo, F., & Quintanilla, R. A. (2022) · Translational Neurodegeneration · doi:10.1186/s40035-022-00308-y · Cited by 80
Insights into Computational Drug Repurposing for Neurodegenerative Disease
Paranjpe, M. D., Taubes, A. L., & Sirota, M. (2019) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2019.06.003 · Cited by 72
Neuroinflammation in Huntington’s disease: From animal models to clinical therapeutics
Jia, Q., Li, S., Li, X.-J., & Yin, P. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1088124 · Cited by 70
Dedifferentiation and neuronal repression define familial Alzheimer’s disease
Caldwell, A. B., Liu, Q., Schroth, G. P., Galasko, D. R., Yuan, S. H., Wagner, S. L., & Subramaniam, S. (2020) · Science Advances · doi:10.1126/sciadv.aba5933 · Cited by 69
High-Density Electrical Recording and Impedance Imaging With a Multi-Modal CMOS Multi-Electrode Array Chip
Miccoli, B., López, C. M., Goikoetxea, E., Putzeys, J., Sekeri, M., Krylychkina, O., Chang, S.-W., Firrincieli, A., Andrei, A., Reumers, V., et al. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00641 · Cited by 75
The Gypsy Endogenous Retrovirus Drives Non-Cell-Autonomous Propagation in a Drosophila TDP-43 Model of Neurodegeneration
Chang, Y.-H., & Dubnau, J. (2019) · Current Biology · doi:10.1016/j.cub.2019.07.071 · Cited by 68
Transposable elements as new players in neurodegenerative diseases
Ravel‐Godreuil, C., Znaidi, R., Bonnifet, T., Joshi, R. L., & Fuchs, J. (2021) · FEBS Letters · doi:10.1002/1873-3468.14205 · Cited by 77
Self-triggered click reaction in an Alzheimer's disease model: in situ bifunctional drug synthesis catalyzed by neurotoxic copper accumulated in amyloid-β plaques
Du, Z., Yu, D., Du, X., Scott, P., Ren, J., & Qu, X. (2019) · Chemical Science · doi:10.1039/c9sc04387j · Cited by 67
Alzheimer’s disease patient brain extracts induce multiple pathologies in novel vascularized neuroimmune organoids for disease modeling and drug discovery
Ji, Y., Chen, X., Wang, Z., Meek, C. J., McLean, J. L., Yang, Y., Yuan, C., Rochet, J., Liu, F., & Xu, R. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03041-w · Cited by 74
Region-specific glial homeostatic signature in prion diseases is replaced by a uniform neuroinflammation signature, common for brain regions and prion strains with different cell tropism
Makarava, N., Chang, J. C.-Y., Molesworth, K., & Baskakov, I. V. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104783 · Cited by 64
Organs to Cells and Cells to Organoids: The Evolution of in vitro Central Nervous System Modelling
Pacitti, D., Privolizzi, R., & Bax, B. E. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00129 · Cited by 66
CRISPR System: A High-throughput Toolbox for Research and Treatment of Parkinson’s Disease
Safari, F., Hatam, G., Behzad‐Behbahani, A., Tabar, V. R., Barekati‐Mowahed, M., Petramfar, P., & Khademi, F. (2019) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-019-00761-w · Cited by 66
A novel glaucoma approach: Stem cell regeneration of the trabecular meshwork
Coulon, S. J., Schuman, J. S., Du, Y., Fard, M. R. B., Ethier, C. R., & Stamer, W. D. (2022) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2022.101063 · Cited by 62
Chronic corticosterone aggravates behavioral and neuronal symptomatology in a mouse model of alpha-synuclein pathology
Burtscher, J., Copin, J., Rodrigues, J., Kumar, S. T., Chiki, A., de Suduiraut, I. G., Sandi, C., & Lashuel, H. A. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.08.007 · Cited by 61
Chronotherapies for Parkinson’s disease
Fifel, K., & Videnović, A. (2019) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2019.01.002 · Cited by 58
Age-related changes in social behaviours in the 5xFAD mouse model of Alzheimer’s disease
Kosel, F., Muñoz, P., Yang, J., Wong, A. A., & Franklin, T. B. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.01.029 · Cited by 57
Oxidative Stress in Tauopathies: From Cause to Therapy
Bartolomé, F. B., Carro, E., & Alquézar, C. (2022) · Antioxidants · doi:10.3390/antiox11081421 · Cited by 59
Heavy Metal Mediated Progressive Degeneration and Its Noxious Effects on Brain Microenvironment
Murumulla, L., Bandaru, L. J. M., & Challa, S. (2023) · Biological Trace Element Research · doi:10.1007/s12011-023-03778-x · Cited by 59
Integrative proteomics identifies a conserved Aβ amyloid responsome, novel plaque proteins, and pathology modifiers in Alzheimer’s disease
Levites, Y., Dammer, E. B., Ran, Y., Tsering, W., Duong, D. M., Abreha, M. H., Gadhavi, J. D., Lolo, K., Trejo‐Lopez, J. A., Phillips, J., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101669 · Cited by 60
Self-citation
Are some animal models more equal than others? A case study on the translational value of animal models of efficacy for Alzheimer's disease
Veening-Griffioen, D. H., Ferreira, G. S., van Meer, P. J. K., Boon, W., Wied, C. C. G., Moors, E. H. M., & Schellekens, H. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172524 · Cited by 59
Blood-brain barrier-on-a-chip for brain disease modeling and drug testing
Cui, B., & Cho, S. (2022) · BMB Reports · doi:10.5483/bmbrep.2022.55.5.043 · Cited by 59
Impact of Aging on the 6-OHDA-Induced Rat Model of Parkinson’s Disease
Barata‐Antunes, S., Teixeira, F. G., Mendes-Pinheiro, B., Domingues, A. V., Vilaça-Faria, H., Marote, A., Silva, D., Sousa, R. A., & Salgado, A. J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103459 · Cited by 56
Single-cell mapping of lipid metabolites using an infrared probe in human-derived model systems
Bai, Y., Camargo, C. M., Glasauer, S. M. K., Gifford, R., Tian, X., Longhini, A. P., & Kosik, K. S. (2024) · Nature Communications · doi:10.1038/s41467-023-44675-0 · Cited by 57
Modeling neurodegenerative diseases with cerebral organoids and other three-dimensional culture systems: focus on Alzheimer’s disease
Venkataraman, L., Fair, S. R., McElroy, C. A., Hester, M. E., & Fu, H. (2020) · Stem Cell Reviews and Reports · doi:10.1007/s12015-020-10068-9 · Cited by 55
Classic and evolving animal models in Parkinson's disease
Pingale, T. D., & Gupta, G. L. (2020) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2020.173060 · Cited by 58
Mice in translational neuroscience: What R we doing?
Azkona, G., & Sánchez‐Pernaute, R. (2022) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2022.102330 · Cited by 59
The role of glia in protein aggregation
Li, Q., & Haney, M. S. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105015 · Cited by 54
Heterocellular spheroids of the neurovascular blood-brain barrier as a platform for personalized nanoneuromedicine
Kumarasamy, M., & Sosnik, A. (2021) · iScience · doi:10.1016/j.isci.2021.102183 · Cited by 52
Induced pluripotent stem cell-based organ-on-a-chip as personalized drug screening tools: A focus on neurodegenerative disorders
Fanizza, F., Campanile, M., Forloni, G., Giordano, C., & Albani, D. (2022) · Journal of Tissue Engineering · doi:10.1177/20417314221095339 · Cited by 55
The Disease Modification Conundrum in Parkinson’s Disease: Failures and Hopes
Mari, Z. K., & Mestre, T. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.810860 · Cited by 50
CRISPR and iPSCs: Recent Developments and Future Perspectives in Neurodegenerative Disease Modelling, Research, and Therapeutics
Sen, T., & Thummer, R. P. (2022) · Neurotoxicity Research · doi:10.1007/s12640-022-00564-w · Cited by 52
A Mouse Model to Test Novel Therapeutics for Parkinson's Disease: an Update on the Thy1-aSyn (“line 61”) Mice
Richter, F., Stanojlović, M., Käufer, C., Gericke, B., & Feja, M. (2023) · Neurotherapeutics · doi:10.1007/s13311-022-01338-0 · Cited by 52
Single-Cell RNA Sequencing in Parkinson’s Disease
Ma, S., & Lim, S. B. (2021) · Biomedicines · doi:10.3390/biomedicines9040368 · Cited by 50
SRT1720 as an SIRT1 activator for alleviating paraquat-induced models of Parkinson's disease
Chao, C.-C., Huang, C., Cheng, J., Chiou, C., Lee, I., Yang, Y.-C., Hsu, T.-H., Yei, C.-E., Lin, P.-Y., Chen, J., et al. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102534 · Cited by 49
Development and Application of Brain Region–Specific Organoids for Investigating Psychiatric Disorders
Zhang, Z., Wang, X., Park, S. S., Song, H., & Ming, G. (2022) · Biological Psychiatry · doi:10.1016/j.biopsych.2022.12.015 · Cited by 49
Lymphocyte Activation Gene 3 (Lag3) Contributes to α-Synucleinopathy in α-Synuclein Transgenic Mice
Gu, H., Yang, X., Mao, X., Xu, E., Qi, C., Wang, H., Brahmachari, S., York, B., Sriparna, M., Li, A., et al. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.656426 · Cited by 49
Self-citation
Quantification of Dendritic Spines Remodeling under Physiological Stimuli and in Pathological Conditions
Bączyńska, E., Pels, K. K., Basu, S., Włodarczyk, J., & Ruszczycki, B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22084053 · Cited by 49
Insulin-like growth factor II prevents oxidative and neuronal damage in cellular and mice models of Parkinson's disease
Martín‐Montañez, E., Valverde, N., de Guevara‐Miranda, D. L., Lara, E., Romero‐Zerbo, S., Millón, C., Boraldi, F., Ávila‐Gámiz, F., Pérez-Cano, A. M., Garrido‐Gil, P., et al. (2021) · Redox Biology · doi:10.1016/j.redox.2021.102095 · Cited by 47
Engineered 3D immuno-glial-neurovascular human miBrain model
Stanton, A. E., Bubnys, A., Agbas, E., James, B. T., Park, D. S., Jiang, A. Y. L., Pinals, R. L., Liu, L., Truong, N., Loon, A. R., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2511596122 · Cited by 51
Alzheimer’s Disease: From Immune Homeostasis to Neuroinflammatory Condition
Cariddi, L. P., Mauri, M. F., Cosentino, M., Versino, M., & Marino, F. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113008 · Cited by 45
Assessing Drug Administration Techniques in Zebrafish Models of Neurological Disease
Chaoul, V., Dib, E., Bedran, J., Khoury, C., Shmoury, O., Harb, F., & Soueid, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914898 · Cited by 47
An acetylcholinesterase inhibitor, donepezil, increases anxiety and cortisol levels in adult zebrafish
Giacomini, A. C. V. V., Bueno, B. W., Marcon, L., Scolari, N., Genário, R., Demin, K. A., Kolesnikova, T. O., Kalueff, A. V., & de Abreu, M. S. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881120944155 · Cited by 48
Utilization of 3D bioprinting technology in creating human tissue and organoid models for preclinical drug research – State-of-the-art
Frankowski, J., Kurzątkowska, M., Sobczak, M., & Piotrowska, U. (2023) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2023.123313 · Cited by 44
Gut microbiome and amyotrophic lateral sclerosis: a systematic review of current evidence
Sun, J., Huang, T., Debelius, J. W., & Fang, F. (2021) · Journal of Internal Medicine · doi:10.1111/joim.13336 · Cited by 43

Authors: Dawson, T. M., Golde, T. E., & Lagier-Tourenne, C.
Affiliations: Johns Hopkins University (US)
University of Florida (US)
Corresponding author: Dawson, Ted M.
Golde, Todd E.
ORCID: Dawson, Ted M.
Golde, Todd E.
Lagier-Tourenne, Clotilde
Venue: Nature Neuroscience
Publisher: Springer Science and Business Media LLC
Published: 2018-09-24
Volume: 21
Issue: 10
Pages: 1370-1379
ISSN: 1097-6256 (ISSN-L)
1546-1726
DOI: 10.1038/s41593-018-0236-8
PMC: PMC6615039
OpenAlex: W2891411797
Cited by: 576
References: 151
Citations by year: 2026: 59 · 2025: 73 · 2024: 89 · 2023: 72 · 2022: 88 · 2021: 79 · 2020: 70 · 2019: 41 · 2018: 4
FWCI: 6.37
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: Nature Neuroscience (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institute on Aging (R01AG018454, U01AG046139, P50AG047266)
National Cancer Institute (P01CA166009)
National Institute of Neurological Disorders and Stroke (R21NS098006, R01NS087227, R01NS082205, P50NS038377)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
Keywords: animal models, neurodegenerative diseases, Alzheimer's disease, Parkinson's disease, frontotemporal dementia, amyotrophic lateral sclerosis, rodent models, translatability, disease modeling
MeSH terms: Animals, Disease Models, Animal, Humans, Neurodegenerative Diseases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Animal models of neurodegenerative diseases

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks